RN7SL263P

Across TCGA pan-cancer cohorts, RN7SL263P RNA differs between tumor and matched normal tissue in 13 of 18 cancer types tested, making tumor–normal expression one of RN7SL263P’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where RN7SL263P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RN7SL263P is over-expressed in tumor, although a few such as KIRP and KIRC show the opposite, repressed pattern.

HNSC, UCEC, and LUSC are the cancer types where RN7SL263P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL263P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	Male	II,III,IV	+0.623	<.001	8	view →
UCEC	All	All	+0.506	<.001	6	view →
LUSC	Male	All	+0.490	<.001	5	view →
LUAD	All	All	+0.429	.002	5	view →
LIHC	All	All	+0.146	.003	5	view →
CHOL	All	II,III,IV	+1.009	<.001	4	view →
KIRP	All	All	−0.299	.003	3	view →
THCA	All	III,IV	+0.294	.017	3	view →
COAD	All	II,III,IV	+0.257	.005	3	view →
READ	Female	All	+0.810	.018	2	view →
PAAD	All	All	+0.649	.045	2	view →
KICH	Female	All	+0.276	.041	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 13 lineages.

RN7SL263P–HNSC

Open the HNSC breakdown →